Census team members and Zixin Pharmaceutical Leaders
Li Daning, chairman of the Ginseng International Standards and Technology Alliance, awarded the flag to the census team
Qiu Deliang, Director of Jilin Provincial Administration of Traditional Chinese Medicine, awarded the flag to the census team
“The national census germplasm resources special census team is assembled and ready! Please instruct!”
At 11 o'clock on the morning of July 1, 2015, along with the majestic march, the work rigs of the national ginseng germplasm resources special census started.
This special census is a particularly important component of the fourth national census of Chinese medicine resources. The census will last for three months and the journey is tens of thousands of kilometers. It is a "big touch" of the ginseng situation in China. After the census, a precise and large ginseng database will be established. The team that completed this task of hardship and glory is Jilin Zixin Pharmaceutical Co., Ltd., which was commissioned by the National Traditional Chinese Medicine Administration's Chinese Medicine Resources Census Pilot Work Office, based on the Jilin Province Ginseng Germplasm Resources Special Census Team. It will also cooperate with the Beijing Genomics Institute of the Chinese Academy of Sciences, Changchun University of Traditional Chinese Medicine, and the Jilin Province Ginseng Science Research Institute to form a national census resource special census team. This is the responsibility of a company for social responsibility, and it is also a practice of the enterprise for the national industry.
Li Daning: The ginseng census is a must, and it is imperative
On the morning of July 1, Dunhua City, Jilin Province, a wholly-owned subsidiary of Zixin Pharmaceutical, and an outfield of Jilin Cao Dan Pharmaceutical. Former Deputy Director of the State Administration of Traditional Chinese Medicine, Director of the Modern Chinese Medicine Resource Monitoring and Technical Service Center, Li Daning, Chairman of the ginseng International Standards and Technology Alliance, Deputy Director of the Jilin Provincial Health Planning Commission, Director of the Provincial Administration of Traditional Chinese Medicine, and the Provincial Traditional Chinese Medicine Resource Census Pilot Office Director Qiu Deliang, leader of the expert group of the Jilin Provincial Traditional Chinese Medicine Resource Census Office, Qu Xiaobo, vice president of Changchun University of Traditional Chinese Medicine, deputy head of the expert group of the Jilin Provincial Traditional Chinese Medicine Resource Census Office, Qiu Zhidong, dean of the School of Pharmacy, Changchun University of Traditional Chinese Medicine, Researcher Wang Xumin, Beijing Institute of Genomics, Chinese Academy of Sciences, Key Laboratory of Genomics Science and Information, Tang Wenzhong, Secretary of Dunhua Municipal Committee, Dou Qingguo, Member of the Standing Committee of Dunhua Municipal Committee, Director of Development Zone Zhou Jinxing, Deputy General Manager of Jilin Zixin Pharmaceutical Co., Ltd. Guests such as Zhong Yunxiang attended the ceremony and witnessed a scene of pivotal significance in the development of China's ginseng industry.
According to Li Daning, ginseng is an important Chinese medicine resource in China and has a certain influence in the world. The ginseng industry is a resource industry in Jilin Province, and the development of Jilin ginseng is also constantly moving forward. The State Administration of Traditional Chinese Medicine and relevant state ministries and commissions are very concerned about the development of ginseng industry. The fourth general survey of Chinese medicine resources laid a good foundation for the special census of ginseng in terms of methods, techniques and organizational forms. Therefore, a special survey of ginseng germplasm resources was carried out in a timely and timely manner. It should be said that it is a matter of course. Things that are imperative. He also said that this work will be well integrated with the special plans for regional development and ginseng industry development in accordance with the technical specifications of the Chinese medicine resource census and the construction requirements of the data repository for the census of Chinese medicine resources. It will lay a solid foundation for the next step of the development of China's ginseng industry, and will play a huge role in promoting scientific research, industry and local economic development.
Qiu Deliang: Perseverance in business and responsibility for national industry
Qiu Deliang said in an interview: The census work has a total of four tasks. First, we must find out the bottom of the family. Second, we must conduct research on the traditional drug use knowledge of Chinese medicine and the related situation of enterprises, pharmacies, and hospital medications. Third, we must establish a germplasm resource monitoring station. Fourth, we must establish a seed seedling base. In addition, a seed resource pool should be established. A low-temperature seed resource pool should be established to freeze the collected seeds. After many years, the plant may not exist, but there is still a seed bank. Therefore, this resource census is very significant, and the task is very arduous and cumbersome. The development of the ginseng industry is indeed a time when it is impossible to wait.
Regarding the efforts and efforts of Zixin Pharmaceutical in this census work, Qiu Deliang said: "As a company, it is possible to spend such great energy to do this thing. This is the attachment to this cause and the national industry. One is responsible. The ginseng census is a basic and strategic work. How much is invested now? It is not something that can be seen immediately in recent years. It may be after many generations. But for the development of Chinese medicine, especially ginseng This is of great significance. Therefore, this basic and strategic work, the enterprise has the courage to undertake, this is a national consciousness, but also a responsibility. Especially in Jilin Province, the king of the herb is in Jilin, born in Changbai Mountain. In the process of treating and saving people and protecting human health for thousands of years, it plays an irreplaceable role. Today, the development of ginseng industry really needs us to make more efforts. How can we really make this brand bigger and stronger? Basic work is especially important. We must collect the germplasm resources accurately and save their biological information. These basic work must be To be done. Zixin Pharmaceutical can have such a strategic height, and it really reflects that this is a responsible and truly practical enterprise. Of course, this census is very difficult, how can good things be done well, and we must have a scientific spirit. Hard work and selfless dedication."
Wang Xumin: Let the national gems "ginseng" shine again
"We are confident that this census resource census will be a benchmark for the 'fourth national Chinese medicine census', leaving a sample bank, a resource map, a information library, and a textbook. Of course, we also want to stay A good story. In 1987, China completed the third national survey of Chinese medicine resources. Today, 28 years later, we all have the honor to participate in the fourth national survey of Chinese medicine resources. We also have more and more advanced scientific equipment. I believe We can do better. In the next 28 years, everyone will be proud to participate in today's activities. Our work will surely make the Chinese nation's gem 'ginseng' shine again." This is the Beijing Genomics of the Chinese Academy of Sciences. Researcher Wang Xumin, Researcher, Key Laboratory of Genomics Science and Information, gave a speech at the census launching ceremony.
Wang Xumin and Zixin Pharmaceutical are attached to ginseng. In 2010, Zixin Pharmaceutical took the lead in organizing the implementation of the Ginseng Genome Project. Wang Xumin saw the determination and confidence of Zixin Pharmaceutical to be bigger, stronger and more ginseng. In 2012, Zixin Pharmaceutical undertook the census of Jilin Province ginseng germplasm resources under the leadership of the Jilin Provincial Administration of Traditional Chinese Medicine and the Jilin Province Traditional Chinese Medicine Resource Census Pilot Office. Wang Xumin also participated in the census research work. At that time, Zixin Pharmaceutical Co., Ltd., together with the Beijing Genomics Institute of the Chinese Academy of Sciences, set up a special census team for Jilin Province ginseng germplasm resources. After scientifically developing a census plan and carefully planning and implementing it, it lasted more than 100 days and the total journey was over 10,000 kilometers. The special census of ginseng germplasm resources in Jilin Province was collected, more than 1000 ginseng specimens were collected, more than 30,000 ginseng scientific research samples and more than 5,000 soil samples were produced. A large amount of ginseng cultivation information was collected, and the ginseng genome map database was further improved. It has provided strong technical support for the development of ginseng industry in Jilin Province.
In combination with his own research field, Wang Xumin said that many scientific research is inseparable from ginseng germplasm resources, which are not only physical resources, but also deeper genetic resources, which requires germplasm resources from the present diversity. Excavate more genetic resources and rescue and protect genetic resources. Carry out a national census resource survey, scientifically increase the systematic scientific research on ginseng from resources to genes, explore in depth at the genome level, carry out the breeding and planting of ginseng excellent varieties, and solve the ginseng cultivation and genetic intervention by scientific means. Diseases and other issues, ginseng into a high-quality anti-reverse, environmentally friendly green Chinese medicine.
At the end of Wang Xumin’s speech, there is such a poem: “The ginseng treasure is deep in the mountains, the world is used to save people, and the resources are censused. I am looking at my Chinese summer. Zixin Pharmaceutical has the responsibility to benefit the country and benefit the people. Digging deep into resource broadcasting, the Chinese medicine industry is shining."